ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 54 | +14.9% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 47 | -37.3% | 0.00% | – |
| Q4 2018 | $3,000 | -50.0% | 75 | -24.2% | 0.00% | – |
| Q3 2018 | $6,000 | +20.0% | 99 | +20.7% | 0.00% | – |
| Q2 2018 | $5,000 | -37.5% | 82 | -34.4% | 0.00% | – |
| Q1 2018 | $8,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | 0.0% | 125 | -17.2% | 0.00% | – |
| Q3 2017 | $8,000 | +14.3% | 151 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | 0.0% | 151 | +11.9% | 0.00% | – |
| Q1 2017 | $7,000 | 0.0% | 135 | +15.4% | 0.00% | – |
| Q4 2016 | $7,000 | -12.5% | 117 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +700.0% | 117 | +588.2% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |